Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial
Andrea M. Gross, Geraldine O’Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G. Herrick, Staci Martin, Steven P. Angus, Jack F. Shern, Steven D. Rhodes, Jared C. Foster, Larry Rubinstein, Andrea Baldwin, Christopher Davis, Shelley A.H. Dixon, Margaret Fagan, Mary Jane Ong, Pamela L. Wolters, Mary Anne Tamula, Olivia H. Reid, Hari Sankaran, Fang Fang, Jeevan Prasaad Govindharajulu, Alice T. Browne, Rosandra N. Kaplan, Kara Heisey, Thomas J. On, Xiaoling Xuei, Xiyuan Zhang, Barry C. Johnson, Ralph E. Parchment, D. Wade Clapp, Apurva K. Srivastava, James H. Doroshow, Alice P. Chen, Brigitte C. Widemann
Topics & Concepts
SelumetinibMedicineNeurofibromatosisAdverse effectDysgeusiaInternal medicineRashPediatric cancerCancerOncologySurgeryPathologyColorectal cancerKRASNeurofibromatosis and Schwannoma CasesSarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments